Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.

Christine A Goetz1, Ian R Harmon, Jennifer J O'Neil

  • 1Center for Immunology, Cancer Center, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|June 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automating neoantigen selection for personalized cancer vaccine design.

medRxiv : the preprint server for health sciences·2026
Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026
Same author

Analysis of CD8 Cytotoxic T-Cells in Patients With Myelodysplastic Neoplasms and T-Cell Large Granulocyte Lymphocytic Leukemia.

European journal of haematology·2026
Same author

Complement Anaphylatoxin Receptors, Complement Protein C3 Receptor 1 and Complement Protein C5 Receptor 1, Are Dual Contributors of Chronic-Plus-Binge-Induced Hepatic Inflammation and Injury.

The American journal of pathology·2026
Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026
Same author

NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Constitutively active STAT5 signaling in mice drives B cell development by altering early T cell progenitor commitment and inducing the B cell regulator Pax5.

Area of Science:

  • Immunology
  • Developmental Biology
  • Molecular Biology

Background:

  • Lymphocyte lineage commitment is crucial for adaptive immunity but its molecular regulation is not fully understood.
  • The Interleukin-7 Receptor (IL7R) pathway, particularly its downstream effector STAT5, plays a role in lymphocyte development.
  • Understanding STAT5's precise function is key to deciphering lineage commitment pathways.

Purpose of the Study:

  • To investigate the role of STAT5 signaling in lymphocyte lineage commitment.
  • To determine how constitutive STAT5 activation affects B cell and T cell progenitor development.
  • To elucidate the molecular mechanisms by which STAT5 influences lineage decisions.

Main Methods:

  • Generation of transgenic mice expressing a constitutively active form of STAT5 (STAT5b-CA).

Related Experiment Videos

  • Analysis of thymocyte populations using flow cytometry and BrdU labeling.
  • Assessment of gene expression, including Bcl-xL and Pax5, and protein-DNA interactions (STAT5 binding to Pax5 promoter).
  • Main Results:

    • STAT5b-CA mice showed a 40-fold increase in thymic pro-B cells, not due to proliferation but a 4-fold increase in survival linked to Bcl-xL.
    • STAT5-induced Bcl-xL and enhanced survival were insufficient to drive thymic B cell development alone.
    • Crucially, STAT5 activation redirected early T cell progenitors (ETPs) to the B cell lineage by inducing Pax5 expression, while inhibiting T cell commitment.
    • STAT5 was found to bind the Pax5 promoter in ETPs, confirming direct regulation.

    Conclusions:

    • STAT5 signaling is a critical determinant of lymphocyte lineage commitment, capable of redirecting T cell progenitors towards the B cell fate.
    • STAT5-mediated induction of Pax5 in ETPs is a key mechanism driving B cell development.
    • Differential IL-7R expression on progenitor subsets leads to distinct STAT5 signaling, ensuring proper B and T cell development in specific microenvironments.